[1]
2025. Spectrum of BCR-ABL Mutations and Treatment Outcomes in Imatinib-Resistant CML Patients: A Retrospective Analysis from a Tertiary Centre in South India. Journal of Carcinogenesis. 24, 4 (Nov. 2025), 261–270. DOI:https://doi.org/10.64149/J.Carcinog.24.4.261-270.